UM/Sylvester Oncogenomics Core Facility is Awarded Novel Gene Analysis System
The University of Miami Sylvester Comprehensive Cancer Center has been chosen as one of the final sites for the placement of the Early Access nCounter Analysis System, a genetic analysis system created by NanoString Technologies. This is the last step before the company launches the commercial system, at the ABRF2008 (Association of Biomolecular Resource Facilities) meeting in Salt Lake City, held February 8-12th. The device will be used in the Oncogenomics Core Facility, led by Toumy Guettouche, Ph.D., associate scientist, who calls this “cutting edge technology.” Being awarded this system puts UM/Sylvester in elite company as there are only four of these devices in use around the country. Besides UM/Sylvester, the Early Access nCounter Analysis System has been awarded to Baylor University, University of Washington, and the California Institute of Technology.
The nCounter Analysis System uses a novel digital technology that enables direct measurement of gene expression and offers high levels of sensitivity and precision. The technology uses molecular barcodes and single molecule imaging to detect and count hundreds of unique transcripts in a single reaction. The system is comprised of a fully automated sample prep station, a digital analyzer, molecular barcodes and all other reagents needed to perform the analysis. It is meant to give scientists the ability to obtain more data in less time, using less starting material, all without compromising quality.
“The nCounter Analysis System will be a valuable addition to our facility,” said Dr Guettouche. “The high level of multiplex analysis together with a unique approach in transcript quantification should allow us to complete our gene expression validation projects in a fraction of the time it would take with alternative approaches.”
NanoString Technologies is a life sciences equipment company headquartered in Seattle.